Comparison of Clinical Outcomes of Diabetes Mellitus Patients with COVID-19 Confirmed Diabetes Mellitus Patients at One of the Hospital Bantul
Downloads
SARS-CoV-2-infected patients with comorbid DM are very likely to experience a significant reduction in glycemic control and eventually require adjustment of antidiabetic treatment to optimize clinical outcomes. The results of data collected by the COVID-19 Handling Task Force, the total number of cases in Indonesia that were confirmed positive for COVID-19 had comorbidities, one of which was Diabetes Mellitus 33.6%. This study aimed to determine whether or not there were differences in clinical outcomes of DM patients with confirmed COVID-19 and DM without confirmed COVID-19 at One of Hospital Bantul. This type of research is observational with a cross-sectional design. Secondary data in the form of medical records. Sampling was carried out using a simple random sampling method with the Lemeshow formula. The data were analyzed using the Mann-Whitney test in bivariate analysis. The results showed that the clinical outcome of type 2 DM patients with confirmed COVID-19 was the GDS target value (38.9%) and the GDS target value (61.1%). The clinical outcome of patients with type 2 diabetes who did not have confirmed COVID-19 was that the GDS target value (55.6%) was achieved and the GDS target value was not reached (44.4%). The results of the Mann-Whitney test showed a significant difference in clinical outcome p=0.046 between DM type 2 confirmed COVID-19 and DM type 2 not confirmed COVID-19. It can be concluded that DM patients with confirmed COVID-19 have different clinical outcomes than DM patients without confirmed COVID-19.
Downloads
Kusumawardani N, Damayanti KW, Styawaty T, and Dwinta, Eliza, Rosyida RW. Pocket Book: Cerdas Dalam Penanganan Diabetes Melitus. Yogyakarta: LP2M Universitas Alma Ata; 2021.
Lu JJ. Experience Of A Radiation Oncology Center Operating During The COVID‐19 Outbreak. Advances in Radiation Oncology. 2020;5(4):548‐549. doi: https://doi.org/10.1016/j.adro.2020.04.003
Hikmawati I, Setiyabudi R. Hipertensi dan Diabetes Militus Sebagai Penyakit Penyerta Utama COVID-19 di Indonesia. Semnas LPPM UMP. 2021;0(4):95–100. doi: https://semnaslppm.ump.ac.id/index.php/semnaslppm/article/view/224
Soesanto E, Istiarti T, Pietojo H. Praktik Lansia Hipertensi dalam Mengendalikan Kesehatan Diri di Wilayah Puskesmas Mranggen Demak. Jurnal Promosi Kesehatan Indonesia. 2018;5(4):127-139. doi: https://doi.org/10.14710/jpki.7.3.127-139.
Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, et al. Practical Recommendations For The Management Of Diabetes In Patients With COVID-19. Lancet Diabetes Endocrinol. 2020;8(6):546–50. doi: http://dx.doi.org/10.1016/S2213-8587(20)30152-2.
Prasad K, Harsha AD, Ishara R, Vithiya R, Piyumi SAW, Nilukshana Y, et al. Prevention and Management Of COVID-19 Among Patients With Diabetes: An Appraisal Of The Literature. Diabetologia. 2020;63(8):1440–1452. doi: 10.1007/s00125-020-05164-x.
Palash K, Karen LJ, Michael H, Adam MD. Management Of Critically Ill Patients With Type 2 Diabetes: The Need For Personalized Therapy. World Journal Diabetes. 2015;6(5):693–706. doi: 10.4239/wjd.v6.i5.693
Landstra CP, Koning EJP. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Front Endocrinol (Lausanne). 2021;12(6):1–18. doi: 10.3389/fendo.2021.649525.
Nurida AM, Diyantoro, Aliyah SS, Dwi WI, Prevalence of Diabetes Mellitus Comorbidity in COVID-19 Patients Treated at Selected Hospital in Surabaya. International Journal of Scientific Research in Biological Sciences. 2022;9(1):32-34. doi: https://www.isroset.org/journal/IJSRBS/full_paper_view.php?paper_id=2703.
Raran KNW. Pengaruh Penyakit Komorbid Diabetes Melitus terhadap Recovery Time pada Pasien COVID-19 di RSUP dr. m djamil padang. 2022;3(11):201-229. doi: https://doi.org/10.30596/jih.v3i4.12234.
Kurnianto E, Putra DH, Fannya P, Dewi DR. Tinjauan Karakteristik Pasien Dengan Kasus Positif COVID-19di Puskesmas Kecamatan Matraman. 2021;9(2):102–8. doi: https://doi.org/10.47007/inohim.v9i2.270.
Asri M, Dita H, Malik R. Evaluasi Adherensi Pengobatan Pasien Diabetes Melitus Tipe 2 di Era Pandemi COVID-19. Human Care. 2021;6(2):396–405. doi: 10.25077/jsfk.7.1.15-22.2020.
Ratnasari PMD, Andayani TM, Endarti D. Analisis Outcome Klinis Berdasarkan Kualitas Hidup dan Biaya Medik Langsung Pasien Diabetes Melitus Tipe 2. Jurnal Sains Farmasi Klinis. 2020;7(1):15. doi: 10.25077/jsfk.7.1.15-22.2020.
Nurayati L, Adriani M. Hubungan Aktifitas Fisik dengan Kadar Gula Darah Puasa Penderita Diabetes Melitus Tipe 2. Amerta Nutrition. 2017;1(2):80. doi: https://doi.org/10.20473/amnt.v1i2.2017.80-87.
Putri, Putra, Mariko. Hubungan Usia, Jenis Kelamin Dan Gejala Dengan Kejadian COVID-19 di Sumatera barat. Artik Penelit. 2021;44(2):104–11. doi: http://jurnalmka.fk.unand.ac.id/index.php/art/article/view/818.
Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology. 2021;64(1):36–47. doi: 10.1159/000512592.
Indonesia. Laporan Nasional Riskesdas 2018. Jakarta: Badan Penelitian dan Pengembangan Kesehatan Riset; 2018.
Kistianita AN, Yunus M, Gayatri RW. Analisis Faktor Risiko Diabetes Mellitus Tipe 2 Pada Usia Produktif Dengan Pendekatan Who Stepwise Step 1 (Core/Inti) Di Puskesmas Kendalkerep Kota Malang. Preventia The Indonesian Journal of Public Health. 2018;3(1):85. doi: http://dx.doi.org/10.17977/um044v3i1p85-108.
Yosmar R, Almasdy D, Rahma F. Survei Risiko Penyakit Diabetes Melitus Terhadap Kesehatan Masyarakat Kota Padang. Jurnal Sains Farmasi dan Klinis. 2018;5(9):134–41. doi: 10.25077/jsfk.5.2.134-141.2018.
Isnaini N, Ratnasari R. Faktor Risiko Mempengaruhi Kejadian Diabetes Mellitus Tipe Dua. Jurnal Kebidanan dan Keperawatan Aisyiyah. 2018;14(1):59–68. doi: https://doi.org/10.31101/jkk.550.
Annisa M. Faktor-Faktor yang Berhubungan dengan Kejadian Komplikasi Sirkulasi Perifer Pasien DM Tipe 2 di RS Haji Medan Tahun 2019-2020 [Skripsi]. Universitas Sumatera Utara; 2021.
Badawi A, Ryoo SG. Prevalence of Comorbidities in The Middle East Respiratory Syndrome Coronavirus (MERS-CoV): A Systematic Review And Meta-Analysis. International Journal of Infectious Diseases . 2016;49(1):129–33. doi: http://dx.doi.org/10.1016/j.ijid.2016.06.015.
Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. COVID-19 in Critically Ill Patients in the Seattle Region — Case Series. New England Journal of Medicine. 2020;382(21):2012–22. doi: 10.1056/NEJMoa2004500.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13. doi: http://dx.doi.org/10.1016/S0140-6736(20)30211-7.
Eltom MA, Babiker MAH, Eliadarous HE, Yassin K, Noor SK, Elmadhoun WM, Ahmed MH. Increasing Prevalence of Type 2 Diabetes Mellitus and Impact of Ethnicity in North Sudan. Diabetes Research and Clinical Practice. 2018;136(2):93–9. doi: 10.1016/j.diabres.2017.11.034.
Elmadhoun WM, Noor SK, Ibrahim AAA, Sarra MHA. Prevalence of Diabetes Mellitus and Its Risk Factors In Urban Communities Of North Sudan: Population-based study. Journal Diabetes. 2016;8(6):839–46. doi: 10.1111/1753-0407.12364.
Trusda SAD, Purbaningsih W, Budiman B, Fitriadi SSN. Characteristics of Patients with Type 2 Diabetes Mellitus in Al-Ihsan Regional General Hospital. Global Medical and Health Communication. 2021;9(2):150–7. doi: https://doi.org/10.29313/gmhc.v9i2.8123.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, Regional And Country-Level Diabetes Prevalence Estimates For 2021 And Projections For 2045. Diabetes Res Clin Pract. 2022;183(1):109119. doi: https://doi.org/10.1016/j.diabres.2021.109119.
Saputri EG, Setiuani O, Astoria N. Hubungan Riwayat Pajanan Pestisida Dengan Kejadian Diabetes Melitus Tipe 2 Pada Petani Penyemprot Di Kecamatan Ngablak Kabupaten Magelang. Jurnal Kesehatan Masyarakat. 2018;6(1):645–53. doi: https://doi.org/10.14710/jkm.v6i1.20200.
Sufian K, Khadeja IOF, Awadalkareem AA, Musa K, Hisham M, Abdelrahim, et al. The Increasing Prevalence of Diabetes Mellitus in COVID-19 Patients : Is it a Matter of Diabetogenicity?. Journal of Research in Medical and Dental Science. 2022;12(3):14–20. doi: https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1880441.
Megawati F, Agustini NPD, Krismayanti NLPD. Studi Retrospektif Terapi Antidiabetik Pada Penderita Diabetes Melitus Rawat Inap Di Rumah Sakit Umum Ari Canti Periode 2018. Medical Journal of Indonesia. 2020;6(1):28–32. doi: https://doi.org/10.36733/medicamento.v6i1.718.
Widiastuti L. Perbedaan Kualitas Hidup Pasien COVID-19 dengan Comorbid. J Keperawatan Silampari. 2021;5(11):233–9. doi: https://doi.org/10.31539/jks.v5i1.2833
Zhu L, She Z-G, Cheng S, Qin JJ. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metabolisme. 2020;31(6):1068–77. doi: 10.1016/j.cmet.2020.04.021.
Fu Y, Hu L, Ren HW, Zuo Y, Chen S, Zhang QS, et al. Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes. International Journal Endocrinology. 2022;4(7):9838923. doi: 10.1155/2022/9322332.
Abdi A, Jalilian M, Ahmadi P, Vlaisavljevic Z. Diabetes and COVID-19: A Systematic Review On The Current Evidences. Diabetes Research and Clinical Practice. 2020;166(7):1–15. doi: 10.1016/j.diabres.2020.108347.
Fox C, Kilvert A. Bersahabat dengan Diabetes Tipe 2. Depok: Penebar Plus; 2010.
Paul EM, Rinaldo B. Stress Hyperglycemia: An Essential Survival Response!. Critical Care. 2013;6(3):305. doi: 10.1186/cc12514.
Bode B, Garrett V, Messler J, McFarland R, Crowe J, Booth R, et al. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. Journal of Diabetes Science and Technology. 2020;14(4):813–21. doi: 10.1177/1932296820924469.
Bindom SM, Lazartigues E. The Sweeter Side of ACE2: Physiological Evidence For A Role In Diabetes. Molecular and Cellular Endocrinology. 2009;302(2):193–202. doi: 10.1016/j.mce.2008.09.020.
Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS Coronavirus to Its Receptor Damages Islets and Causes Acute Diabetes. Acta Diabetologica. 2010;47(3):193–9. doi: 10.1007/s00592-009-0109-4.
Naomi H, Peter K, Partha K, Jackie O, Matt C, Andy W, et al. Risk Factors For COVID-19-Related Mortality In People With Type 1 And Type 2 Diabetes In England: A Population-Based Cohort Study. Lancet Diabetes Endocrinology. 2020;8(1):19–21. doi: 10.1016/S2213-8587(20)30271-0.
Kornum JB, Thomsen RW, Riis A, Lervang H-H, Schønheyder HC, Sørensen HT. Type 2 Diabetes and Pneumonia Outcomes. Diabetes Care. 2007;30(9):2251–7. doi: 10.2337/dc06-2417.
Muniyappa R, Gubbi S. COVID-19 Pandemic, Coronaviruses, And Diabetes Mellitus. American Journal of Physiology-Endocrinology and Metabolism. 2020;318(5):736–41. doi: 10.1152/ajpendo.00124.2020.
Aulia S. Hubungan Tingkat Pengetahuan Terhadap Outcome Klinik Pasien Diabetes Mellitus Tipe 2 di Puskesmas Kasihan II [Skripsi]. Universitas Jenderal Achmad Yani Yogyakarta; 2021.
Aprilia T. Hubungan Tingkat Pengetahuan Terhadap Outcome Klinik Pasien Diabetes Melitus Tipe 2 di Puskesmas Gamping 1 [Skripsi]. Universitas Jenderal Achmad Yani Yogyakarta; 2021.
Indonesia. Pedoman Pengelolaan dan Pencegahan Diabetes Militus Tipe 2 Dewasa di Indonesia 2019. Jakarta: Kementrian Kesehatan RI Pusat Data dan Informasi; 2019.
Andreani FV, Belladonna M, Hendrianingtyas M. Hubungan Antara Gula Darah Sewaktu dan Puasa Dengan Perubahan Skor Nihss pada Stroke Iskemik Akut. Jurnal Kedokteran Diponegoro. 2018;7(1):185–98. doi: https://doi.org/10.14710/dmj.v7i1.19361.
Indirawaty I, Adrian A, Sudirman S, Syarif KR. Hubungan Pengetahuan dan Dukungan Keluarga dengan Rutinitas dalam Mengontrol Gula Darah pada Penderita Diabetes Melitus Tipe 2. Aksara Jurnal Ilmu Pendidikan Nonformal. 2021;7(1):67. doi: http://dx.doi.org/10.37905/aksara.7.1.67-78.2021.
Malik MA. Gambaran Kadar Kolesterol Total Darah pada Mahasiswa Angkatan 2011 Fakultas Kedokteran Universitas Sam Ratulangi dengan Indeks Massa Tubuh 18,5-22,9 kg/m2. Jurnal e-Biomedik. 2014;1(2):991–6. doi: https://doi.org/10.35790/ebm.v1i2.3310.
Nita R. Gambaran Kontrol dan Kadar Gula Darah pada Pasien Diabetes Melitus di Poliklinik Penyakit dalam RSJ Prof. Dr. Soerojo Magelang [Skripsi]. Universitas Diponegoro; 2015.
You JH, Lee SA, Chun S-Y, Song SO, Lee B W, Kim DJ, et al. Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea. Endocrinology and Metabolisme (Seoul, Korea). 2020 31(12):901–8. doi: http://e-enm.org/journal/view.php?doi=10.3803/EnM.2020.787.
Vitara D, Estiningsih D, Sarwadhamana RJ. Kajian Penggunaan Suplemen Kesehatan Terhadap Keberhasilan Terapi COVID-19. Indonesian Pharmacy and Natural Medicine Journal. 2023; 7(2): 96-105 doi: 10.21927/inpharnmed.v7i2.3876
Masfiyah L, Estiningsih D, Astuti WS, Hadi NS. Analysis of Length of Stay (LOS) of Diabetes Mellitus Patients with COVID-19 Confirmed at One of Bantul Private Hospitals. Jurnal Kefarmasian Indonesia. 2023;13(2): 159-166 doi: https://doi.org/10.22435/jki.v13i2.6608 159.
Copyright (c) 2024 Jurnal Kefarmasian Indonesia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
